Active substances
Dextrose + Potassium chloride + Sodium chloride + Tri
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ORS 30GM SACHET | 3.5,1.5,2.9,20 g,g,g,g | Powder for oral solution in sachet · Oral use | 10 Sachet | SAR 9.30 | Generic · OTC | National Pharmaceutical Industries Co. (SAOG) | Valid |
| ORS New (10 SACHET) | 0.52,0.3,0.58,2.7 g,g,g,g | Powder for oral solution in sachet · Oral use | 10 Sachet | SAR 7.20 | Generic · OTC | National Pharmaceutical Industries Co. (SAOG) | Valid |
| ORS New (50 SACHET) | 0.52,0.3,0.58,2.7 g,g,g,g | Powder for oral solution in sachet · Oral use | 50 Sachet | SAR 30.30 | Generic · OTC | National Pharmaceutical Industries Co. (SAOG) | Valid |
Indications — CHI Daman Drug Formulary
BACTRIAL INFECTIONS OF THE GASTROINTESTINAL TRACT - VIBRIO CHOLERAE; DIARRHEA; TRAVELLER'S DIARRHEA; VIRAL GASTROENTERITIS
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.